atx crypto club

190307125401-01-martin-shkreli-file-restricted-super-tease.jpg

Anon Ymous

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in the Brooklyn borough of New York, U.S., on Thursday, Aug. 3, 2017. The 34-year-old Shkreli, known as “Pharma Bro,” is accused of taking money from investors in his previous hedge funds and using it to start Retrophin, then using the drug-development company’s cash to pay them back. Photographer: Peter Foley/Bloomberg

Back to top